These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8383603)

  • 1. A purine analogue reduces kainate neurotoxicity in vivo.
    MacGregor DG; Chishti SK; Stone TW
    Biochem Soc Trans; 1993 Feb; 21(1):12S. PubMed ID: 8383603
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of kainate-induced excitotoxicity by a purine analogue.
    MacGregor DG; Stone TW
    Neuroreport; 1992 Jun; 3(6):536-8. PubMed ID: 1327268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of purine protection against kainate-induced increase in hippocampal [3H]-PK11195 binding.
    Miller WJ; MacGregor DG; Stone TW
    Brain Res Bull; 1994; 34(2):133-6. PubMed ID: 8044687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade by 1,3-dipropyl-8-cyclopentylxanthine (CPX) of purine protection against kainate neurotoxicity.
    Macgregor DG; Stone TW
    Brain Res; 1994 May; 644(2):339-42. PubMed ID: 8050046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.
    MacGregor DG; Stone TW
    Br J Pharmacol; 1993 Jun; 109(2):316-21. PubMed ID: 8358536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention by a purine analogue of kainate-induced neuropathology in rat hippocampus.
    MacGregor DG; Jones PA; Maxwell WL; Graham DI; Stone TW
    Brain Res; 1996 Jun; 725(1):115-20. PubMed ID: 8828594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.
    MacGregor DG; Miller WJ; Stone TW
    Br J Pharmacol; 1993 Sep; 110(1):470-6. PubMed ID: 8220909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by an adenosine analogue against kainate-induced extrahippocampal neuropathology.
    MacGregor DG; Graham DI; Jones PA; Stone TW
    Gen Pharmacol; 1998 Aug; 31(2):233-8. PubMed ID: 9688465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic ascorbate protects against kainate neurotoxicity.
    MacGregor DG; Higgins MJ; Ogilvy HV; Watson MW; Stone TW
    Biochem Soc Trans; 1994 Feb; 22(1):17S. PubMed ID: 8206217
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for interactions between [3H]glutamate and [3H]kainic acid binding sites in rat striatal membranes. Possible relevance for kainic acid neurotoxicity.
    Fuxe K; Agnati LF; Celani MF
    Neurosci Lett; 1983 Mar; 35(3):233-8. PubMed ID: 6843895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus.
    MacGregor DG; Higgins MJ; Jones PA; Maxwell WL; Watson MW; Graham DI; Stone TW
    Brain Res; 1996 Jul; 727(1-2):133-44. PubMed ID: 8842391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine in organophosphate-induced neurotoxicity.
    Ho IK; Hoskins B
    J Toxicol Sci; 1990 Dec; 15 Suppl 4():159-61. PubMed ID: 1966055
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroprotective effect of dapsone against quinolinate- and kainate-induced striatal neurotoxicities in rats.
    Santamaría A; Ordaz-Moreno J; Rubio-Osornio M; Solís-Hernández F; Ríos C
    Pharmacol Toxicol; 1997 Dec; 81(6):271-5. PubMed ID: 9444668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanine nucleotides inhibit NMDA and kainate-induced neurotoxicity in cultured rat hippocampal and neocortical neurons.
    Morciano M; Ortinau S; Zimmermann H
    Neurochem Int; 2004 Jul; 45(1):95-101. PubMed ID: 15082227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retina.
    Seki T; Nakatani M; Taki C; Shinohara Y; Ozawa M; Nishimura S; Ito H; Shioda S
    Ann N Y Acad Sci; 2006 Jul; 1070():531-4. PubMed ID: 16888220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen effects on kainate-induced toxicity in primary cultures of rat cortical neurons.
    Kajta M; Lasoń W
    Acta Neurobiol Exp (Wars); 2000; 60(3):365-9. PubMed ID: 11016078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pyrimidine derivative BW 1003C87 protects against excitotoxic lesions induced by kainate in the rat striatum.
    Moncada CR; Arvin B; Meldrum BS
    Neurosci Lett; 1994 Sep; 179(1-2):17-20. PubMed ID: 7531313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia protects against the neurotoxicity of kainic acid.
    Pohle W; Rauca C
    Brain Res; 1994 May; 644(2):297-304. PubMed ID: 8050040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systemically administered kainic acid.
    Fariello RG; Golden GT; Pisa M
    Neurology; 1982 Mar; 32(3):241-5. PubMed ID: 7199633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid involvement in epileptogenic and neurovisceral activity.
    Pinsky C; Bose R; Hall A; Glavin GB
    Prog Clin Biol Res; 1990; 328():421-4. PubMed ID: 2154802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.